Pharma Journalist 9091 posts 0 comments

The energy coming out of this year’s ATS meeting was unmistakable: respiratory medicine is entering a new era of scientific ambition, cross‑industry collaboration, and patient‑centred…
Read More...

Gilead Sciences announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval to Hepcludex® (bulevirtide-gmod) 8.5 mg for the treatment of adults living…
Read More...

AbbVie announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending approval of MAVIRET®…
Read More...

AstraZeneca and Daiichi Sankyo announced that the U.S. Food and Drug Administration (FDA) has approved Datroway (datopotamab deruxtecan) for adults with unresectable or metastatic…
Read More...

Regeneron Pharmaceuticals said the European Medicines Agency (EMA) has accepted for review under its Accelerated Assessment pathway the Marketing Authorization Application (MAA) for…
Read More...

Concept Life Sciences has entered a strategic partnership with OpenBench to accelerate early-stage drug discovery for biotechnology companies through a success-based artificial…
Read More...

Bristol Myers Squibb and Anthropic have entered a strategic agreement to deploy Anthropic’s Claude artificial intelligence platform across Bristol Myers Squibb’s global operations,…
Read More...

FUJIFILM Cellular Dynamics has inaugurated a new headquarters and induced pluripotent stem cell (iPSC) development and manufacturing facility in Madison, Wisconsin, significantly…
Read More...

Eli Lilly and Company reported positive topline results from its Phase 3 TRIUMPH-1 clinical trial, showing that investigational obesity treatment retatrutide delivered substantial and…
Read More...

Gilead Sciences has completed its previously announced acquisition of Germany-based biotechnology company Tubulis GmbH, strengthening its oncology pipeline with next-generation…
Read More...